Heart disease does not arrive without warning. In the vast majority of cases, it develops over years – driven by a combination of risk factors that damage the blood vessels, promote the buildup of fatty deposits in the arteries, impair the heart’s electrical system, or place the heart under sustained pressure.
Understanding your own cardiac risk profile is one of the most important steps you can take for your long-term health. For Sri Lankan patients, this understanding needs to take into account not only the universal cardiovascular risk factors recognised globally, but also several factors that are particularly prevalent in the Sri Lankan context.
This guide covers the key cardiac risk factors, explains how each one damages the cardiovascular system, and provides evidence-based guidance on how to address them.
Why Cardiac Risk Matters in Sri Lanka
Cardiovascular disease is the leading cause of death in Sri Lanka, accounting for approximately 30 percent of all deaths. The burden is not distributed evenly – several risk factors are particularly prevalent in the Sri Lankan population:
- Diabetes affects an estimated 23 percent of Sri Lankan adults – one of the highest rates in South Asia
- Hypertension affects between 28 and 51 percent of the adult population depending on the region, with a large proportion undiagnosed
- Betel and areca nut chewing – a widespread cultural practice – carries specific cardiovascular risks that are relevant to a significant proportion of the Sri Lankan adult population
- Physical inactivity and obesity are rising alongside Sri Lanka’s economic development and urbanisation
- Rheumatic heart disease, driven by streptococcal infections in childhood, contributes to the burden of valve disease and atrial fibrillation
Understanding these risks – and acting on them – is the most effective tool available for reducing the burden of heart disease in Sri Lanka at the individual and population level.
What Is Cardiovascular Risk?
Cardiovascular risk refers to the probability that a person will develop a cardiovascular event – heart attack, stroke, heart failure, or cardiovascular death – over a defined period, typically 10 years.
Risk is not destiny. A person with multiple risk factors does not inevitably develop heart disease. But their probability of doing so is higher than someone without those risk factors, and the purpose of risk assessment is to identify people who will benefit most from intervention – whether through lifestyle modification, medication, or both.
Several validated risk calculators are used to estimate individual cardiovascular risk. These typically incorporate age, sex, blood pressure, cholesterol levels, smoking status, and diabetes status. In Sri Lanka, tools calibrated for South Asian populations tend to be more accurate than tools developed primarily for Western populations, as South Asians develop cardiovascular disease at a younger age and at lower cholesterol levels than Western populations.
Hypertension: The Silent Risk Factor
Hypertension – high blood pressure – is one of the most powerful and most prevalent cardiovascular risk factors in Sri Lanka.
What Is Hypertension?
Blood pressure is the force that blood exerts against the walls of the arteries as the heart pumps it around the body. It is measured as two numbers – systolic pressure (the pressure when the heart contracts) over diastolic pressure (the pressure between beats), expressed in millimetres of mercury (mmHg).
Blood pressure is classified as:
- Normal: below 120/80 mmHg
- Elevated: 120-129 / below 80 mmHg
- Stage 1 hypertension: 130-139 / 80-89 mmHg
- Stage 2 hypertension: 140 or above / 90 or above mmHg
- Hypertensive crisis: above 180 / above 120 mmHg – requires urgent medical attention
How Hypertension Damages the Heart and Vessels
Sustained high blood pressure forces the heart to work harder than normal with every beat. Over years, this leads to:
- Left ventricular hypertrophy – the heart muscle thickens in response to the increased workload, ultimately reducing the heart’s ability to fill and pump effectively
- Accelerated atherosclerosis – high blood pressure damages the inner lining of the arteries (the endothelium), making them more susceptible to the buildup of fatty plaques that cause coronary artery disease and stroke
- Kidney damage – high blood pressure is a leading cause of kidney disease, and damaged kidneys further elevate blood pressure, creating a damaging cycle
- Aortic aneurysm – high blood pressure promotes weakening and dilatation of the aorta
Why Hypertension Is Called a Silent Risk Factor
High blood pressure rarely causes symptoms until it reaches extreme levels or until organ damage has already occurred. The vast majority of people with hypertension feel entirely normal – which is why regular blood pressure checks are essential, and why such a large proportion of Sri Lankan patients with hypertension remain undiagnosed.
Managing Hypertension
The goal of hypertension treatment is to reduce blood pressure to below 130/80 mmHg in most patients, and to below 140/80 mmHg in elderly patients as a minimum. This is achieved through:
- Lifestyle modification – weight reduction, dietary sodium restriction, regular aerobic exercise, reduction of alcohol intake, and smoking cessation. These measures can reduce systolic blood pressure by 5 to 15 mmHg in compliant patients
- Antihypertensive medication – multiple effective classes of medication are available, including ACE inhibitors, ARBs, calcium channel blockers, thiazide diuretics, and beta-blockers. Most patients with Stage 2 hypertension require more than one medication to achieve target blood pressure
- Regular monitoring – blood pressure at home using a validated device provides a more accurate picture of daily blood pressure than occasional clinic readings
Diabetes and Heart Disease: A Dangerous Partnership
Diabetes and cardiovascular disease are so closely linked that some experts have described type 2 diabetes as a cardiovascular disease with a metabolic component. In Sri Lanka, where diabetes affects approximately 23 percent of adults, this connection has profound public health implications.
How Diabetes Damages the Cardiovascular System
Diabetes causes cardiovascular damage through multiple pathways:
- Accelerated atherosclerosis – elevated blood glucose levels damage the endothelium and promote the formation and progression of atherosclerotic plaques. Coronary artery disease progresses more rapidly and affects more vessels in patients with diabetes
- Endothelial dysfunction – the inner lining of blood vessels loses its normal protective functions, becoming pro-inflammatory and pro-thrombotic
- Autonomic neuropathy – diabetic nerve damage can affect the autonomic nerves that regulate heart rate and blood pressure, contributing to silent ischaemia (lack of blood flow to the heart without the normal warning of chest pain) and postural hypotension
- Cardiomyopathy – diabetes causes direct damage to the heart muscle independent of coronary artery disease, leading to diabetic cardiomyopathy – impaired heart muscle function that can progress to heart failure
- Prothrombotic state – diabetes promotes a state of increased blood clotting tendency
Diabetes and Heart Attack Presentation
As noted in our article on heart attack vs heartburn for Sri Lankan patients, diabetic autonomic neuropathy means that patients with diabetes are more likely to experience silent heart attacks – heart attacks without the typical warning of chest pain. They may present instead with breathlessness, nausea, or fatigue, or the heart attack may be detected only on a subsequent ECG without the patient ever having been aware of the event.
Managing Cardiac Risk in Diabetes
For diabetic patients, cardiovascular risk reduction requires:
- Blood glucose control – targeting HbA1c below 7 percent (or an individualised target as advised by the treating team). SGLT2 inhibitors and GLP-1 receptor agonists are the preferred antidiabetic medications in patients with established cardiovascular disease or high cardiovascular risk, as they have demonstrated cardiovascular outcome benefits beyond glucose lowering
- Blood pressure control – targeting below 130/80 mmHg, preferably with ACE inhibitors or ARBs as first-line agents due to their renal protective effects
- Cholesterol management – statin therapy for virtually all diabetic adults over 40 with additional risk factors
- Antiplatelet therapy – aspirin in diabetic patients with established cardiovascular disease
- Regular cardiac screening – including ECG, and echocardiography to assess heart muscle function in patients with long-standing diabetes
High Cholesterol and Dyslipidaemia
Cholesterol is a fatty substance that plays essential roles in the body – forming cell membranes, producing hormones, and enabling vitamin D synthesis. But when certain cholesterol fractions are elevated, particularly low-density lipoprotein (LDL) cholesterol, the risk of atherosclerosis and coronary artery disease rises significantly.
Understanding the Lipid Profile
- LDL cholesterol – often called the bad cholesterol. LDL particles carry cholesterol to tissues but can deposit it in arterial walls, promoting plaque formation. Lower is better
- HDL cholesterol – often called the good cholesterol. HDL particles carry cholesterol away from tissues back to the liver for excretion. Higher is better
- Triglycerides – another type of fat in the blood. Elevated triglycerides (particularly above 1.7 mmol/L) are associated with increased cardiovascular risk and are often elevated in patients with diabetes, obesity, and metabolic syndrome
- Total cholesterol – the sum of all cholesterol fractions. Less clinically useful than individual fractions but still used in some risk calculators
South Asian Lipid Patterns
South Asians, including Sri Lankans, tend to develop cardiovascular disease at lower LDL cholesterol levels than Western populations – suggesting that LDL is not the only relevant factor and that other metabolic features, including higher triglycerides and lower HDL, contribute disproportionately to risk in this population.
Managing Dyslipidaemia
- Statins are the cornerstone of medical cholesterol management. They reduce LDL cholesterol by 30 to 55 percent depending on the agent and dose, and have demonstrated reduction in cardiovascular events across all risk categories in which they have been studied
- Dietary modification – reducing saturated fat and trans fat, increasing fibre and plant sterols
- Ezetimibe – an additional cholesterol-lowering agent used when statins alone are insufficient
- PCSK9 inhibitors – newer injectable agents for patients with very high cardiovascular risk whose LDL is inadequately controlled on maximum statin therapy
- Target LDL – varies by risk category. In patients with established cardiovascular disease, the target is typically LDL below 1.4 mmol/L (55 mg/dL)
Smoking and Tobacco Use
Smoking is one of the most powerful and most modifiable cardiovascular risk factors. In Sri Lanka, the prevalence of smoking is higher in men than women, but the cardiovascular consequences are profound regardless of sex.
How Smoking Damages the Cardiovascular System
Tobacco smoke contains thousands of chemicals that damage the cardiovascular system through multiple mechanisms:
- Endothelial damage – tobacco chemicals directly damage the inner lining of blood vessels, accelerating atherosclerosis
- Increased blood pressure – nicotine raises heart rate and blood pressure acutely with each cigarette
- Pro-thrombotic effects – smoking increases platelet aggregation and promotes clot formation, significantly elevating the risk of acute coronary events
- Reduced HDL cholesterol – smoking lowers the protective good cholesterol fraction
- Carbon monoxide – reduces the oxygen-carrying capacity of the blood, placing additional strain on the heart muscle
Smokers have a two to four times higher risk of coronary artery disease compared to non-smokers. The risk is dose-dependent – heavier smoking carries higher risk – but even light smoking or passive smoking carries significant cardiovascular risk.
The Benefit of Quitting
The cardiovascular risk benefit of smoking cessation is substantial and occurs relatively quickly:
- Within 20 minutes of the last cigarette, heart rate and blood pressure begin to normalise
- Within 12 hours, carbon monoxide levels in the blood fall to normal
- Within one year of quitting, the excess risk of coronary heart disease falls by 50 percent
- Within 5 to 15 years of quitting, the risk of stroke returns to that of a non-smoker
- Within 15 years of quitting, the risk of coronary heart disease approaches that of a non-smoker
No medication, dietary change, or lifestyle intervention produces cardiovascular risk reduction as rapid and as large as smoking cessation.
Betel and Areca Nut Chewing: A Sri Lanka-Specific Cardiac Risk
Betel quid and areca nut chewing is a widespread practice across Sri Lanka, particularly in rural communities and among older generations. The practice involves chewing a combination of areca nut (the seed of the Areca catechu palm), betel leaf, and slaked lime – often combined with tobacco (as gutka or paan masala).
Cardiovascular Effects of Areca Nut
Areca nut contains arecoline – an alkaloid with significant cardiovascular effects:
- Sympathomimetic activity – arecoline stimulates the sympathetic nervous system, raising heart rate and blood pressure with each chewing episode
- Pro-arrhythmic effects – areca nut chewing has been associated with an increased risk of cardiac arrhythmias, including atrial fibrillation. The arecoline content directly affects cardiac electrical activity
- Vasoconstrictive effects – arecoline causes constriction of blood vessels, reducing coronary blood flow and raising blood pressure
Association With Cardiovascular Disease
Multiple studies from South and South-East Asian populations have identified areca nut chewing as an independent risk factor for:
- Hypertension
- Atrial fibrillation and other arrhythmias
- Coronary artery disease
- Metabolic syndrome (a cluster of risk factors including abdominal obesity, high blood pressure, elevated blood glucose, and abnormal cholesterol levels that collectively increase cardiovascular risk)
The cardiovascular risk of areca nut chewing is compounded when tobacco is added to the quid, as is common in Sri Lanka. The combination of areca nut and tobacco creates a more potent cardiovascular risk than either substance alone.
The Key Message for Sri Lankan Patients
Betel and areca nut chewing is not a neutral cultural practice from a cardiovascular perspective. For Sri Lankan patients with existing hypertension, diabetes, or known cardiac conditions, it is a modifiable risk factor that significantly elevates cardiovascular risk and should be discontinued as part of cardiac risk management.
Obesity and Physical Inactivity
Obesity and physical inactivity are closely linked and are rising in Sri Lanka alongside economic development, urbanisation, and dietary change.
How Obesity Increases Cardiac Risk
Excess body weight – particularly abdominal (visceral) obesity – is associated with:
- Elevated blood pressure
- Insulin resistance and type 2 diabetes
- Elevated triglycerides and reduced HDL cholesterol
- Inflammation of the blood vessel walls
- Sleep apnoea – which independently elevates cardiac risk through nocturnal hypoxia and sympathetic nervous system activation
- Increased workload on the heart – the heart must pump blood to a larger body mass
The cardiovascular risk associated with obesity is not purely mediated through these traditional risk factors. Visceral adiposity appears to have direct pro-inflammatory and pro-atherosclerotic effects independent of blood pressure and cholesterol.
The Benefits of Physical Activity
Regular aerobic exercise is one of the most powerful interventions available for cardiovascular risk reduction:
- Reduces resting blood pressure by 5 to 8 mmHg
- Improves insulin sensitivity and blood glucose control
- Raises HDL cholesterol
- Reduces resting heart rate
- Reduces body weight and visceral adiposity
- Reduces resting sympathetic nervous system activity
- Improves endothelial function
Current guidelines recommend at least 150 minutes per week of moderate-intensity aerobic activity (such as brisk walking, cycling, or swimming) for cardiovascular risk reduction.
Atrial Fibrillation as a Risk Category of Its Own
Atrial fibrillation (AF) deserves mention as a cardiovascular risk factor in its own right – not just as a consequence of other risk factors, but as a condition that independently elevates the risk of stroke and heart failure.
AF increases the risk of stroke fivefold compared to patients in normal sinus rhythm. AF-related strokes tend to be more severe and more disabling than other stroke types.
The risk factors for developing AF overlap significantly with general cardiovascular risk factors – hypertension, diabetes, obesity, sleep apnoea, and areca nut chewing all increase the likelihood of developing AF. This means that patients with multiple traditional cardiovascular risk factors are also at elevated risk of developing AF.
For Sri Lankan patients, regular pulse checks – feeling the pulse to detect an irregular rhythm – are a simple and effective screening tool for AF. An irregular pulse in a patient over 65 warrants an ECG to assess for AF.
Our article on heart rhythm disorders and atrial fibrillation for Sri Lankan patients covers AF diagnosis and treatment in full detail.
Family History and Genetic Risk
A family history of premature cardiovascular disease – defined as a first-degree male relative (father or brother) with a heart attack or coronary revascularisation before the age of 55, or a first-degree female relative before the age of 65 – is an independent cardiovascular risk factor.
What Family History Tells Us
A positive family history increases the likelihood of inherited factors contributing to cardiovascular risk – including familial hypercholesterolaemia (a genetic condition causing very high LDL cholesterol from birth), inherited hypertension, and genetic variants that promote atherosclerosis.
Familial Hypercholesterolaemia
Familial hypercholesterolaemia (FH) is an underdiagnosed genetic condition in Sri Lanka in which LDL cholesterol is markedly elevated from birth, causing premature and severe coronary artery disease. Patients with FH may develop heart attacks in their 30s and 40s without other conventional risk factors. FH should be suspected in:
- Patients with LDL cholesterol above 4.9 mmol/L (190 mg/dL)
- Patients with a family history of premature heart disease
- Patients with physical signs of cholesterol deposits (xanthomas around the tendons or xanthelasmas around the eyes)
If FH is suspected, genetic testing and cascade screening of first-degree relatives is recommended. Treatment requires high-intensity statin therapy from an early age.
Age, Sex, and Hormonal Factors
Age
The risk of cardiovascular disease rises progressively with age. Atherosclerosis is a process that begins in childhood and adolescence but takes decades to reach the point of clinical events. Most heart attacks and strokes occur in people over 60.
However, the presence of multiple risk factors can substantially advance the timeline. Sri Lankan patients with diabetes, hypertension, and other risk factors may develop significant coronary artery disease in their 40s and 50s.
Sex
Men develop cardiovascular disease earlier than women – the average age of first heart attack is approximately a decade earlier in men. This difference is partly attributable to the protective effect of oestrogen on the cardiovascular system during the reproductive years.
After menopause, women’s cardiovascular risk rises rapidly, and by age 75, cardiovascular disease is equally prevalent in men and women.
Menopause and Hormonal Factors
The menopausal transition – with its associated fall in oestrogen levels – is associated with adverse changes in cardiovascular risk factors including blood pressure elevation, weight gain, insulin resistance, and unfavourable lipid changes. Sri Lankan women approaching or past menopause with other cardiovascular risk factors should have a formal cardiovascular risk assessment.
How Multiple Risk Factors Multiply Your Risk
The most important concept in cardiovascular risk assessment is that risk factors do not simply add together – they multiply each other’s effects.
A patient with hypertension alone has a moderately elevated risk. A patient with hypertension and diabetes has a risk substantially higher than the sum of either alone. Add smoking, physical inactivity, obesity, and a family history – as is the case for many Sri Lankan patients who present with their first heart attack – and the risk is very high indeed.
This is why global cardiovascular risk assessment – looking at all risk factors together, not in isolation – is more meaningful than focusing on any single abnormal value. A blood pressure of 145/90 mmHg in a healthy 35-year-old non-smoker with normal cholesterol and no diabetes carries a different risk implication than the same blood pressure in a 55-year-old diabetic smoker with a family history of premature heart disease.
Reducing Your Cardiac Risk: What the Evidence Says
The most effective interventions for cardiovascular risk reduction, ranked by strength of evidence:
Smoking Cessation
The single most impactful risk reduction intervention for smokers. No other intervention produces as large or as rapid a cardiovascular risk reduction.
Blood Pressure Control
Reducing systolic blood pressure by 10 mmHg reduces the risk of major cardiovascular events by approximately 20 percent. This is achieved through a combination of lifestyle modification and, where needed, medication.
LDL Cholesterol Reduction
Each 1 mmol/L reduction in LDL cholesterol reduces the risk of major cardiovascular events by approximately 22 percent. Statin therapy is the most effective medical intervention for LDL reduction.
Blood Glucose Control in Diabetes
Good glycaemic control reduces the risk of cardiovascular events, particularly when combined with blood pressure control and statin therapy. Newer agents – SGLT2 inhibitors and GLP-1 agonists – have demonstrated cardiovascular outcome benefits beyond glucose lowering.
Regular Physical Activity
150 minutes per week of moderate aerobic activity reduces cardiovascular mortality by approximately 35 percent compared to physical inactivity.
Dietary Modification
A diet rich in vegetables, fruit, whole grains, legumes, fish, and olive oil (Mediterranean-style diet) is associated with a 30 percent reduction in cardiovascular events in high-risk patients.
Cessation of Betel and Areca Nut Chewing
For Sri Lankan patients who chew betel quid or areca nut, cessation removes a specific and significant source of cardiovascular risk.
Weight Reduction
Even modest weight loss of 5 to 10 percent of body weight significantly improves blood pressure, blood glucose, and lipid levels.
How Amrita Hospitals Supports Sri Lankan Cardiac Patients
For Sri Lankan patients who have been identified as having significant cardiovascular risk – whether through a formal risk assessment, a specialist appointment, or an incidental finding during a routine check – Amrita Hospitals in Kochi offers comprehensive cardiac risk evaluation and management.
This includes:
- Detailed cardiovascular risk assessment combining clinical history, blood tests, and imaging
- Coronary artery calcium scoring – a non-invasive CT-based assessment that quantifies the degree of calcium in the coronary arteries, providing a direct measure of atherosclerotic burden
- Stress testing to identify silent coronary artery disease
- Echocardiography to assess heart structure and function
- Specialist review of risk factor management optimisation
For patients found to have established coronary artery disease requiring intervention, the full range of percutaneous and surgical cardiac treatment options is available. Our article on bypass surgery vs angioplasty for Sri Lankan patients explains the decision between these approaches in detail.
For patients wanting to understand the broader cardiac care available at Amrita Hospitals, our article on why Sri Lankan patients choose Amrita Hospital provides a practical overview of the institution’s capabilities and patient journey support.
To explore the full range of cardiac services available, visit cardiac risk assessment and heart disease treatment in India.
Frequently Asked Questions
At what age should I start having my cardiovascular risk checked? For most adults, cardiovascular risk assessment should begin at age 40 – or earlier if there is a family history of premature heart disease, known diabetes, or other significant risk factors. Sri Lankan adults with diabetes, hypertension, or a family history of heart disease should have a formal cardiovascular risk assessment regardless of age.
Can heart disease be reversed? The atherosclerotic process can be slowed and in some cases partially reversed with aggressive risk factor management – particularly LDL cholesterol reduction and lifestyle modification. However, significant coronary artery disease that has already caused symptoms or reduced blood flow to the heart muscle typically requires revascularisation (stenting or bypass surgery) in addition to risk factor management.
Is betel nut chewing really dangerous for the heart? Yes. Areca nut contains arecoline, which raises blood pressure, affects heart rhythm, and is independently associated with cardiovascular disease in South Asian populations. The risk is compounded when tobacco is added to the quid. Cessation of betel and areca nut chewing is a specific and modifiable cardiovascular risk reduction intervention for Sri Lankan patients.
My father had a heart attack at 50. Does this mean I will too? A family history of premature heart disease is an independent risk factor – it increases your risk but does not make a heart attack inevitable. The appropriate response is a formal cardiovascular risk assessment, with particular attention to lipid levels (to exclude familial hypercholesterolaemia), blood pressure, blood glucose, and lifestyle factors. Acting on modifiable risk factors significantly reduces the risk imparted by family history.
Is aspirin recommended for preventing heart attacks? Aspirin in low doses reduces the risk of recurrent heart attacks and other cardiovascular events in patients who have already had a cardiac event (secondary prevention). However, in people who have not had a cardiovascular event (primary prevention), the cardiovascular benefit of aspirin must be weighed against its bleeding risk – and current guidelines generally do not recommend routine aspirin for primary prevention in patients without established cardiovascular disease.
How often should I have my blood pressure and cholesterol checked? Adults without hypertension or dyslipidaemia should have blood pressure checked at least every two years and lipids checked at least every five years from age 40, or more frequently if there are risk factors. Adults with known hypertension or dyslipidaemia require more frequent monitoring – typically at every medication review appointment. People with diabetes should have lipids and blood pressure checked at least annually.
Conclusion
Cardiovascular risk in Sri Lanka is shaped by a combination of globally recognised risk factors and several that are specific to the Sri Lankan population – including the high prevalence of diabetes, the cultural practice of betel and areca nut chewing, and the burden of rheumatic heart disease.
Understanding your own risk profile is the foundation of cardiovascular prevention. For many Sri Lankan patients, this understanding – combined with action on modifiable risk factors – can significantly reduce the likelihood of a heart attack, stroke, or heart failure over the coming decades.
For Sri Lankan patients who have already been identified as high risk, or who have established cardiovascular disease requiring specialist management, Amrita Info Centre Sri Lanka is here to support access to comprehensive cardiac care at Amrita Hospitals in Kochi – one hour from Colombo, with a full cardiac risk assessment and treatment programme and a coordinated patient pathway from Sri Lanka.